← All trials
NCT01445431
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2011
- Primary completion
- Aug 31, 2011
- Completion date
- Aug 31, 2011
- First posted
- Oct 3, 2011
- Last posted
- Oct 3, 2011
- Enrollment
- 45
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of the PhilippinesLead sponsor
- University of the PhilippinesOverall official - principal investigator
- University of the PhilippinesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.